Severe hemorrhage in a patient with metastatic colorectal cancer

被引:5
|
作者
Oergel, Melanie [1 ]
Horger, Marius [2 ]
Kurth, Ralph [3 ]
Kanz, Lothar [1 ]
Jaschonek, Karl [1 ]
Mayer, Frank [1 ]
Kopp, Hans-Georg [1 ]
机构
[1] Univ Klinikum Tubingen, Med Klin, Tubingen, Germany
[2] Univ Klinikum Tubingen, Radiol Klin, Tubingen, Germany
[3] Univ Klinikum Tubingen, Inst Allgemeine Pathol, Tubingen, Germany
关键词
Colorectal Cancer; Microangiopathic Hemolysis; Disseminated Intravascular Cogulation; DISSEMINATED INTRAVASCULAR COAGULATION; BONE-MARROW; GASTRIC-CANCER; BREAST-CANCER; SOLID TUMORS; MALIGNANCY; STATE; THROMBOCYTOPENIA;
D O I
10.1055/s-0032-1305227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and admission findings: We report on a 65-year-old female patient with a recent diagnosis of adenocarcinoma of the sigmoid colon and massive hematochezia in the context of a general bleeding disorder. Investigations: Disseminated malignant disease with hepatic metastases as well as bone marrow involvement was demonstrated. Moreover, circulating tumor cells were demonstrated by flow cytometry. The patient had right lower quadrant abdominal pain due to a spontaneous psoas intramuscular hematoma. Diagnosis, treatment and course: At the time of admission to our hospital, the patient displayed microangiopathic hemolytic anemia and secondary hyperfibrinolysis with a pronounced bleeding tendency. Moreover, there was an acute renal failure which improved with fluid resuscitation. With immediate chemotherapy consisting of 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX regimen) and cetuximab initiated with the second course, plasmatic coagulation could be stabilized. Consequently, treatment with tranexamic acid, fibrinogen, fresh frozen plasma as well as red blood cell and platelet infusions could be stopped. Continuation of chemotherapy was possible on an outpatient basis and the further course was associated with a good quality of life until her near end. The patient died at home 7 months after initial diagnosis of her colon cancer due to progressive disease with CNS metastases. Conclusions: Disseminated intravascular coagulation with microangiopathic hemolysis and secondary hyperfibrinolysis is a rare albeit possible event in disseminated colorectal cancer, especially when the bone marrow is involved. Treatment of the underlying cause is the most important therapeutic measure.
引用
收藏
页码:1705 / +
页数:36
相关论文
共 50 条
  • [31] Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factors
    Clarke, Stephen J.
    Karapetis, Christos S.
    Gibbs, Peter
    Pavlakis, Nick
    Desai, Jayesh
    Michael, Michael
    Tebbutt, Niall C.
    Price, Tim J.
    Tabernero, Josep
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (02) : 121 - 135
  • [32] Irinotecan-Induced Transient Dysarthria in a Patient With Metastatic Colorectal Cancer: A Case Report
    Inting, Kim Alfred E.
    Piano, Anthony N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [33] Veillonella Bacteremia in a Patient With Metastatic Colorectal Carcinoma
    Karki, Sailesh
    Mainali, Arjun
    Pandey, Sagar
    Uprety, Navodita
    Panigrahi, Kalpana
    Adhikari, Samaj
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [34] Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: Case series analysis
    Wang, Jui-Ho
    King, Tai-Ming
    Chang, Min-Chi
    Hsu, Chao-Wen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (38) : 5427 - 5433
  • [35] Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: Case series analysis
    Jui-Ho Wang
    Tai-Ming King
    Chao-Wen Hsu
    World Journal of Gastroenterology, 2012, 18 (38) : 5427 - 5433
  • [36] Severe hypocalcemia after oral ibandronate in a patient with metastatic breast cancer: a case report
    Avci, Fatma
    Merdin, Alparslan
    Sezgin Goksu, Sema
    Coskun, Hasan Senol
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2014, 29 (01): : 21 - 23
  • [37] Systemic therapy of metastatic colorectal cancer
    Kubicka, S.
    ONKOLOGE, 2014, 20 (08): : 725 - +
  • [38] Strategies to tackle RAS-mutated metastatic colorectal cancer
    Patelli, G.
    Tosi, F.
    Amatu, A.
    Mauri, G.
    Curaba, A.
    Patane, D. A.
    Pani, A.
    Scaglione, F.
    Siena, S.
    Sartore-Bianchi, A.
    ESMO OPEN, 2021, 6 (03)
  • [39] Curative approaches for metastatic colorectal cancer
    Arnold, D.
    Stein, A.
    GASTROENTEROLOGE, 2010, 5 (05): : 430 - 436
  • [40] Cetuximab in the treatment of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) : 243 - 256